ANI
12 May 2022, 19:18 GMT+10
Seoul [South Korea], May 12 (ANI/Global Economic): NeoImmuneTech said on the 11th that it has obtained the approval for a phase 2 clinical trial plan that concomitant administration of US Merck's immune checkpoint inhibitor Keytruda and its T-cell amplifier NT-I7 to patients with glioblastoma from the United States FoodDrug Administration (US FDA).
The phase 2 trial will be led by Professor Jian Campian at the US Mayo Clinic. It will evaluate the safety and treatment efficacy. Merck and NeoImmuneTech will supply Keytruda and NT-I7.
The research team expects the concomitant administration of Keytruda and NT-I7 to improve the survival rate of patients with glioblastoma.
The survival time of glioblastoma is less than 6 months, and the prognosis is very poor. Some chemotherapy drugs and a target anticancer Avastin are used for treatment, but the effectiveness is not significant. Genexine is conducting a clinical trial of the concomitant administration of Avastin and Efineptakin Alfa (GX-I7) in Korea, and NeoImmuneTech plans to test immune checkpoint inhibitor and T-cell amplifier. After the phase 2 trial, it will enter the phase 3 trial of the most likely treatment.
NT-I7 is a drug that amplifies T cell immunity to remove cancer cells and infected cells. Currently, it is under clinical development to treat various deadliest cancers and infectious diseases. (ANI/Global Economic)
Get a daily dose of North Korea Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to North Korea Times.
More InformationLONDON, England: The UK's Telegraph newspaper has reported that Foreign Secretary Liz Truss has proposed that Britain send modern weaponry ...
SHANGHAI, China: The central Shanghai district of Jingan, a key commercial area in China's financial hub, has announced that it ...
KYIV, Ukraine: Andrzej Duda, President of Poland, told lawmakers in Kyiv this week that Ukraine has the right to decide ...
SAN ANTONIO, Texas (ANI/Big News Network): The death toll in the mass shooting incident at a school in Texas now ...
LONDON, England: Citing a U.S. official, the Financial Times reported this week that during the Quad summit in Tokyo, the ...
ATHENS, Greece: In a significant move for Greece, which has intensified its campaign to bring back sculptures from its most ...
SYDNEY, NSW, Australia - Shares across Asia fell on Thursday, with the exception of the Chinese mainland market where modest ...
SANTIAGO, Chile: Easter Island, one of Chile's most important tourist attractions, will reopen to visitors on August 1, the government ...
NEW DEHLI, India: In a move expected to end the country's exports of the raw materials needed to manufacture steel, ...
NEW YORK, New York - The release of the minutes of the Federal Reserve's monetary meeting earlier this month surprisingly ...
WASHINGTON D.C.: A leading U.S. official has said that even if Taiwan is excluded from President Joe Biden's Asian economic ...
MOSCOW, Russia: In the latest escalation of an energy payment dispute with Western nations, Russia's Gazprom has halted gas exports ...